Case Study:
Helping to Reframe and Prioritise the Management of Chronic Insomnia in UK Primary Care
The Client
Our client is dedicated to developing innovative small-molecule medicines for psychiatric/ sleep-related conditions.
Background
Chronic insomnia is a prevalent but under-recognised sleep disorder in the UK, affecting 6.8%–14.9% of adults. It is associated with significant health and economic burdens, yet remains under-diagnosed and poorly managed in primary care.
Opportunity
There was an opportunity to address key gaps in the understanding, diagnosis and management of chronic insomnia and to develop consensus-based recommendations to optimise care pathways across the National Health Service.
Approach
Triducive designed a Delphi approach to engage general practitioners, pharmacists, and sleep specialists.